← All indications
Coinfection
Simultaneous infection of a host organism by two or more pathogens. In virology, coinfection commonly refers to simultaneous infection of a single cell by two or more different viruses.
Drugs by status
Phase 4 trials (7)
Phase 3 trials (3)
Phase 2 trials (1)
Organizations
Organization Involved with Phase 4 Indications (43)
- Abbott
- AbbVie
- Roche
- Gilead Sciences
- ViiV Healthcare
- Merck
- Pfizer
- GlaxoSmithKline
- Derm Research, PLLC
- Fundacion SEIMC-GESIDA
- National Institutes of Health (NIH)
- National Institute of Allergy and Infectious Diseases (NIAID)
- Andaluz Health Service
- University of Washington
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- Instituto Nacional de Enfermedades Respiratorias
- International Antiviral Therapy Evaluation Center (IATEC)
- Kenya Medical Research Institute
- Johns Hopkins University
- South Valley University
- Sichuan University
- Taoyuan General Hospital
- Universidad Autonoma de Madrid
- University of Maryland
- University of Seville
- University of Valencia
- Assiut University
- Sohag University
- University of California, San Francisco
- University of Colorado, Denver
- +13 more
Organization Involved with Phase 3 Indications (18)
- Biocad
- CIHR Canadian HIV Trials Network
- Federal University of Rio Grande do Sul
- McGill University
- Universidade Federal de Santa Maria
- University of Ottawa
- All India Institute of Medical Sciences
- Moscow State University
- Southern Medical University
- Government of Russia
- National Taiwan University
- St. Petersburg City Health Department
- University of Barcelona
- Johnson and Johnson
- Government of Belarus
- People's Liberation Army of China
- Canadian Lung Association
- Humanity & Health Research Centre
Organization Involved with Phase 2 Indications (27)
- Bristol-Myers Squibb
- Replicor Inc.
- AIDS Clinical Trials Group
- French National Agency for Research on AIDS and Viral Hepatitis
- Bamrasnaradura Infectious Diseases Institute
- Chulalongkorn University
- Cornell University
- Radboud University
- Spanish National Health System
- The HIV Netherlands Australia Thailand Research Collaboration
- University of Bern
- University of Bonn
- Centre de Recherche Médicale de Lambaréné
- Kwame Nkrumah University of Science and Technology
- Kumasi Centre for Collaborative Research
- University of Duesseldorf
- Chiangrai Prachanukroh Hospital
- Aix-University of Marseille
- Bhumibol Adulyadej Hospital
- Chonburi Cancer Hospital
- Buddhachinaraj Hospital
- University of Rennes
- Government of Thailand
- University of Burgundy
- Taksin Hospital
- Klang Hospital
- Medecins Sans Frontieres
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (14)
- National Institute for Medical Research, Tanzania
- Yunnan AIDS Care Center
- Catholic University of Health and Allied Sciences
- Kenyatta National Hospital
- Makerere University
- Menoufia University
- Tanta University
- Tata Memorial Hospital
- Fudan University
- University of Cambridge
- University of Nairobi
- HBT Medical College & R.N.Cooper Muncipal Hospital
- Yunnan Provincial Hospital of Infectious Diseases
- Centers for Disease Control and Prevention (CDC)